EA201692438A1 - Пероральная композиция для улучшения системных симптомов, включая чувствительность к холоду - Google Patents

Пероральная композиция для улучшения системных симптомов, включая чувствительность к холоду

Info

Publication number
EA201692438A1
EA201692438A1 EA201692438A EA201692438A EA201692438A1 EA 201692438 A1 EA201692438 A1 EA 201692438A1 EA 201692438 A EA201692438 A EA 201692438A EA 201692438 A EA201692438 A EA 201692438A EA 201692438 A1 EA201692438 A1 EA 201692438A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oral composition
improve system
including cold
cold sensitivity
sensitivity
Prior art date
Application number
EA201692438A
Other languages
English (en)
Other versions
EA034370B1 (ru
Inventor
Кентаро Матсуура
Итиро Кавасэ
Атсуси Савамура
Original Assignee
Ссп Ко. Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ссп Ко. Лтд filed Critical Ссп Ко. Лтд
Publication of EA201692438A1 publication Critical patent/EA201692438A1/ru
Publication of EA034370B1 publication Critical patent/EA034370B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Toxicology (AREA)

Abstract

В заявке описана пероральная композиция, которая может улучшать системные симптомы, такие как чувствительность к холоду. Пероральная композиция включает в качестве эффективного компонента экстракт листьев красного винограда для улучшения симптома, выбранного из группы включающей чувствительность к холоду, общее утомление, общую слабость и "застывшие" плечи или ригидность затылка.
EA201692438A 2014-05-27 2015-05-22 Пероральная композиция для улучшения системных симптомов, включая чувствительность к холоду EA034370B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014108649A JP2015224205A (ja) 2014-05-27 2014-05-27 冷え症等の全身症状改善用経口組成物
PCT/EP2015/061453 WO2015181096A1 (en) 2014-05-27 2015-05-22 Oral composition for improving systemic symptoms including sensitivity to cold

Publications (2)

Publication Number Publication Date
EA201692438A1 true EA201692438A1 (ru) 2017-10-31
EA034370B1 EA034370B1 (ru) 2020-01-31

Family

ID=53264667

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692438A EA034370B1 (ru) 2014-05-27 2015-05-22 Пероральная композиция для улучшения системных симптомов, включая чувствительность к холоду

Country Status (11)

Country Link
US (1) US10695392B2 (ru)
EP (1) EP3148561A1 (ru)
JP (2) JP2015224205A (ru)
KR (1) KR102395338B1 (ru)
CN (1) CN106470694A (ru)
AU (1) AU2015266075B2 (ru)
CA (1) CA2949421A1 (ru)
EA (1) EA034370B1 (ru)
MX (1) MX2016015423A (ru)
PH (1) PH12016502270A1 (ru)
WO (1) WO2015181096A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101925960B1 (ko) * 2016-12-30 2018-12-06 서울대학교 산학협력단 식물 추출물을 포함하는 수족냉증 예방, 치료 및 완화용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3862600B2 (ja) 2001-08-31 2006-12-27 由紀夫 長谷部 卵殻膜含有錠剤
US20040151769A1 (en) 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
SI1581195T1 (sl) 2002-12-31 2010-09-30 Boehringer Ingelheim Int Filmsko obložena tableta ki obsega ekstrakt listov rdeče vinske trte
EP1435242A1 (en) * 2002-12-31 2004-07-07 Pharmaton S.A. Method of improvement of blood circulation
US20040151794A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Method of improvement of blood circulation
JP2005052085A (ja) * 2003-08-05 2005-03-03 Orbis Inc 食品組成物
US20050038125A1 (en) 2003-08-15 2005-02-17 Smit Hobbe Friso Method for the treatment of arthritis and pain
EP1550452A1 (en) 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a antthrombotic agent for the treatment of chronic venous insufficiencies
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
JP4739161B2 (ja) 2005-10-26 2011-08-03 花王株式会社 持久力向上剤
US20090162457A1 (en) 2005-10-26 2009-06-25 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
JP4838772B2 (ja) * 2007-07-18 2011-12-14 敏 新川 肩こり・五十肩・各種関節痛等の改善を目的とした塗布剤
JP2012240956A (ja) * 2011-05-19 2012-12-10 Kakei Gakuen レスベラトロールを含む剤、及び組成物
JP5848042B2 (ja) * 2011-06-29 2016-01-27 株式会社ロッテ 眼疲労抑制組成物及びそれを含む飲食品

Also Published As

Publication number Publication date
WO2015181096A1 (en) 2015-12-03
AU2015266075A1 (en) 2016-12-08
AU2015266075B2 (en) 2020-06-18
JP2015224205A (ja) 2015-12-14
KR102395338B1 (ko) 2022-05-10
PH12016502270A1 (en) 2017-01-30
JP2017529314A (ja) 2017-10-05
MX2016015423A (es) 2017-07-04
CA2949421A1 (en) 2015-12-03
JP6698034B2 (ja) 2020-05-27
EP3148561A1 (en) 2017-04-05
US10695392B2 (en) 2020-06-30
CN106470694A (zh) 2017-03-01
EA034370B1 (ru) 2020-01-31
KR20170005873A (ko) 2017-01-16
US20170202899A1 (en) 2017-07-20

Similar Documents

Publication Publication Date Title
TR201901445T4 (tr) Il2rbeta/yaygın gamma zinciri antikorları.
PH12018500707A1 (en) Anti-human cd19 antibodies with high affinity
EA202092435A2 (ru) Моноклональные антитела против bcma
EP3387600A4 (en) INTEGRATED SYSTEM FOR BACkS-BASED SEARCH, TRADE AND ANALYTICS MACHINES
MX2017007550A (es) Composiciones microencapsuladas de cannabinoides.
MX2019007480A (es) Anticuerpos monoclonales anti-alfa-sinucleina para prevenir la agregacion de tau.
MA40682A (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
WO2016094837A3 (en) Anti-c10orf54 antibodies and uses thereof
CU20190006A7 (es) Composiciones para inhibir masp-3
WO2016098079A3 (en) Compositions and methods for antibodies targeting bmp6
WO2015177175A3 (en) Novel specific-binding polypeptides and uses thereof
EA201691429A1 (ru) МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
WO2016057683A3 (en) Novel anti-nodal antibodies and methods of using same
WO2016020702A8 (en) Anti-tenascin c antibodies and uses thereof
EA201600093A1 (ru) Дигидроксифенильные нейромедиаторные соединения, композиции и способы
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
WO2015022077A8 (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
MX2017006692A (es) Trastornos neurodegenerativos.
EA201692438A1 (ru) Пероральная композиция для улучшения системных симптомов, включая чувствительность к холоду
WO2016109361A3 (en) 3-fluoro-benzonitrile inhibitors of 11-beta-hydroxylase
MA39355A1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MX2018009218A (es) Anticuerpos de cgrp y sus usos.
高橋耕平 et al. Comparison of the AirwayScope® and Macintosh laryngoscope with in-line cervical stabilization by the semi-solid neck collar: manikin study

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM